# Eosera, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/eosera-inc/703b6159-ec09-448d-a592-b17026014ed1

> Inspection records and compliance data for Eosera, Inc. in Fort Worth, Texas. Access full analysis and detailed observations.

---

## Details

- Name: Eosera, Inc.
- FEI Number: 3013559620
- City: Fort Worth
- State: Texas
- Country Name: United States
- Address Line 1: 5000 South Fwy Ste 106
- Zip Code: 76115

## Related Documents

- [483 - Eosera, Inc. - 2026-03-20](https://www.keypedia.com/records/483/eosera-inc/569373ef-b10b-4dfe-a3e9-5471d1621ba6) — source: FDA, date: March 20, 2026
- [FDA Inspection 1308346 - Eosera, Inc. - 2026-03-20](https://www.keypedia.com/records/fda_inspections/eosera-inc/6a760a07-14f0-4bff-8ac2-037a6b847e72) — source: FDA, date: March 20, 2026
- [483 - Eosera, Inc. - 2025-04-28](https://www.keypedia.com/records/483/eosera-inc/4b27806f-0243-4ab2-bea7-648c2df4130f) — source: FDA, date: April 28, 2025
- [483 - Eosera, Inc. - 2025-04-28](https://www.keypedia.com/records/483/eosera-inc/a5bd0ed3-25e7-4571-82cd-abe754c3ecdf) — source: FDA, date: April 28, 2025
- [FDA Inspection 1269635 - Eosera, Inc. - 2025-04-28](https://www.keypedia.com/records/fda_inspections/eosera-inc/d587b33b-e13d-4322-8bcc-32a754573761) — source: FDA, date: April 28, 2025
- [FDA Inspection 1165791 - Eosera, Inc. - 2022-03-01](https://www.keypedia.com/records/fda_inspections/eosera-inc/809c8c78-0695-434f-9552-a3a9c12e8c0c) — classification: Official Action Indicated (OAI), source: FDA, date: March 1, 2022
- [483 - Eosera, Inc. - 2020-01-17](https://www.keypedia.com/records/483/eosera-inc/c776aca9-7268-427b-8184-60a16a1e4ba7) — source: FDA, date: January 17, 2020
- [WARNING_LETTER - Eosera, Inc. - 2020-01-17](https://www.keypedia.com/records/warning_letter/eosera-inc/902d53ce-5022-472e-a89f-cfc852ba42df) — source: FDA, date: January 17, 2020
- [FDA Inspection 1115592 - Eosera, Inc. - 2020-01-17](https://www.keypedia.com/records/fda_inspections/eosera-inc/3221668e-fad4-4ca7-b173-8cba754bd210) — classification: Official Action Indicated (OAI), source: FDA, date: January 17, 2020

## Related Companies

- [Sanofi Pasteur](https://www.keypedia.com/companies/sanofi-pasteur/851434de-295b-430d-b638-f2e9f50b0531)
- [Signature Formulations, LLC](https://www.keypedia.com/companies/signature-formulations-llc/d724b32c-8d17-4320-8e89-b38c3990c497)
- [Hetero Labs Limited (Unit V)](https://www.keypedia.com/companies/hetero-labs-limited-unit-v/2d1a05bb-2577-4d77-9785-7fbfbe0ade5c)
- [TAKA USA, INC. dba Cosmetic Innovations](https://www.keypedia.com/companies/taka-usa-inc-dba-cosmetic-innovations/b5688fbb-faaa-4716-93f5-37cce7b85f23)
- [AIRGAS USA, LLC.](https://www.keypedia.com/companies/airgas-usa-llc/4b907eaf-4756-4ab5-96df-9b7680cb8344)
- [Kolmar Korea Co., Ltd. - Gwanjeong Factory](https://www.keypedia.com/companies/kolmar-korea-co-ltd-gwanjeong-factory/392855b3-652a-43a6-abb2-d78b2b634c5e)
- [TAIWAN BIOTECH CO., LTD.](https://www.keypedia.com/companies/taiwan-biotech-co-ltd/90bf5095-2bd0-4ad1-973c-274a66a5201f)
- [Apothecus Pharmaceutical Corp.](https://www.keypedia.com/companies/apothecus-pharmaceutical-corp/d37c243b-2226-4d18-9931-7a3b915e3199)
- [Grifols Therapeutics LLC](https://www.keypedia.com/companies/grifols-therapeutics-llc/2e4dd489-4e70-4ef7-a1f8-f0267f91fab5)
- [CSL Behring GmbH](https://www.keypedia.com/companies/csl-behring-gmbh/21a38e53-2e5d-4c9e-a287-79597f091cc6)

## Related Officers

- [Investigator](https://www.keypedia.com/people/shanna-n-purdy/7a677cf5-484f-4e9a-91b1-27398411ff32)
- [Investigator](https://www.keypedia.com/people/patty-p-kaewussdangkul/1f0961fc-216e-4580-830a-56a76c0e7cea)
- [Program Division Director](https://www.keypedia.com/people/monica-r-maxwell/e1b3373a-80b0-4023-9aea-b4ac7170c964)
- [investigator](https://www.keypedia.com/people/kevin-t-nguyen/5ae9d562-7e4f-4305-895a-4b39c35acd16)
- [Shelby N. Turner](https://www.keypedia.com/people/shelby-n-turner/77268f33-ae48-4e30-abad-4d79c1077185)